ABSTRACT Balloon dilatation (BD) of bioprosthetic valves was investigated in vivo and in vitro. Four children with stenotic bioprosthetic porcine valves in the pulmonary position underwent BD of the valve 10 to 24 months after its insertion. PERCUTANEOUS balloon dilatation (BD) has been used successfully to relieve stenoses in native pulmonary, -3 aortic,4 and mitral5 valves in both children and adults. In the present study, the BD technique was used to dilate four stenotic porcine bioprosthetic valves in right ventricular-to-pulmonary arterial conduits in children. The favorable experience suggests that balloon dilatation in this setting may be a useful nonoperative modality that may serve to postpone surgical replacement of a valve conduit.
PERCUTANEOUS balloon dilatation (BD) has been used successfully to relieve stenoses in native pulmonary, -3 aortic,4 and mitral5 valves in both children and adults. In the present study, the BD technique was used to dilate four stenotic porcine bioprosthetic valves in right ventricular-to-pulmonary arterial conduits in children. The favorable experience suggests that balloon dilatation in this setting may be a useful nonoperative modality that may serve to postpone surgical replacement of a valve conduit.
Materials and methods
Patient population. In the past 7 years, 41 children have been seen at our institution with porcine (aortic valve) bioprostheses used as pulmonary valves, 39 inserted at our center and two implanted elsewhere. Thirty valves were within conduits and 11 were placed as orthotopic xenografts. Seven patients died in the immediate or early postoperative period and follow-up was available, ranging from 2 months to 6 years 2 months (mean = 2 years 5 months), for 34 patients. Valve failure necessitating intervention occurred in nine children at a mean postoperative time of 2 years and 10 months. Five patients underwent conduit replacement and four recent patients underwent BD. The patients in the BD group are discussed below.
Patient 1, with truncus arteriosus type A-1,6 underwent reparative surgery at the age of 5 months with insertion of a 12 mm porcine valved conduit between the right ventricle and the pulmonary arteries concurrent with closure of the ventricular septal defect (table 1) . At catheterization 10 months after surgery, stenosis of the bioprosthetic valve was found. BD was performed. At repeat catheterization four months after BD, there was only a trivial (6 mm Hg) gradient across the dilated valve, but severe stenosis of the branch right pulmonary artery was found. Replacement of the conduit was perfonned.
Patient 2 had had repair of truncus arteriosus performed elsewhere at 5 months of age. She underwent diagnostic cardiac catheterization at 21/2 years of age at our center, where a stenotic porcine valve was detected. BD of the valve was performed (figure 1) , and an attempt was made to dilate a severely stenotic right pulmonary artery (RPA). This was not successful because the "standard" extrusion catheter was too stiff to be placed in the RPA ostium. Asymmetric pulmonary blood flow was confirmed, with 24% distribution to the right lung. Four months later, a soft extrusion 8 mm balloon catheter was first used to dilate the 2 mm RPA, followed by BD with a standard extrusion 10 mm catheter. Significant improvement in the RPA pulse wave contour was noted (figure 2) and 2 weeks after the BD of the RPA, right lung perfusion was 40%.
Patient 3 underwent repair of coarctation and pulmonary artery banding at 5 weeks of age for transposition of the great arteries, ventricular septal defect, and coarctation of the aorta. Additional palliation was provided by a systemic-to-pulmonary artery anastomosis when the patient was Technique of balloon dilatation. Written informed consent was obtained before each procedure. After completion of hemodynamic and angiographic studies, a No. 7F Goodall-Lubin catheter was advanced across the stenotic valve from a femoral venous approach. A 260 cm long, 0.035 inch thick exchange wire was positioned in a branch pulmonary artery (usually the left) as distally as possible, preferably at the level of the diaphragm, to provide as much "anchor" as possible for the balloon catheter, which was usually stiff and often had to traverse acute angulations within the right heart. Leaving the wire in place, both catheter and sheath were removed. A Mansfield balloon dilatation catheter (usually standard extrusion) was advanced along the wire into the conduit.
The balloon catheter/inflator system was loaded with Renografin 60 diluted to 25% usual strength with flush solution; trapped air was removed from the system. The balloon was not test-inflated because the expanded balloon would not return to a smooth, flat position on the shaft; this made insertion into the BEFORE AFTER patient more difficult and more traumatic on the vein. After advancement through the right heart, the midportion of the balloon was positioned at the stent of the bioprosthetic valve and location was confirmed fluoroscopically with low-pressure (< 1 atmosphere) inflation. High oxygen was administered by face mask throughout the BD procedure. (Although the inflations were maintained only for a short time, it is believed that hypoxia should be avoided in ventricles that are stressed before repair and continue to be pressure-overloaded by the stenotic bioprosthetic valve.) Usually at this point in the procedure, additional sedation and supplemental heparin were necessary. BD was performed at least twice for 20 sec each to an inflation pressure halfway between the recommended pressure and an empirically determined bursting pressure; usually this was 1.0 to 1.5 atmospheres greater than the recommended pressure limit on the package.
Repeat hemodynamic studies -including measurement of cardiac output -and angiography were then performed. The same precautions were taken as during BD of native pulmonary valve stenosis; i.e., contrast was delivered well away from the site of BD. In each case, distal obstruction was found and the same balloon and technique was used to dilate these stenoses. Measurement grids were also filmed to measure precisely the balloon size during inflation. 
Results
Balloon dilatation reduced the average transvalvular gradient from 47.5 to 25 mm Hg and reduced the right ventricular pressure to a level below that of left ventricular pressure (table 2) . In patient 1, right ventricular systolic pressure changed from suprasystemic to 60% of left ventricular systolic pressure ( figure 3 ). In every case, pulmonary artery pressure rose, usually from a relatively nonpulsatile waveform to a normal tracing ( figure 1) . Measurements of the inflated balloon corresponded closely (within 0.2 mm) with the size indicated on the package.
Porcine valve competence was assessed by two-dimensional echocardiography interfaced with Doppler flow instrumentation. Patient 1 had a trace degree of pulmonary regurgitation before BD; this increased to moderate after the procedure. The other three children had no regurgitation before BD; after BD, there was trace regurgitation in two of the three.
The conduit removed from patient 1 four months after BD was grossly intact (figure 4). A proliferative intimal lesion was found approximately 1 cm proximal to the valve cusps. The cusps were intact without tears but were retracted to a partially open position. Histo- : U L S1j 1 1 M 1 1 1 1 1 I   FIGURE 3 . Pressure tracings from patient 1. Left, Before BD, right ventricular (RV) pressure is higher than pressure in the ascending aorta (AAo). Right, After BD, pressure in the AAo has risen, right ventricular pressure has decreased and the RV/Ao pressure ratio has decreased to 0.67 from 1.3. logic examination revealed that the stenotic intimal proliferation was composed of moderately cellular fibrous tissue of indeterminate duration, without hemorrhage or dissection. The valve was mildly calcified at its periphery. The calcific deposits were focal, at the cuspal bases, and in the (porcine) aortic wall incorporated into the bioprosthesis. Obstruction at the level of the proximal fibrous tissue proliferation was greater than that at the level of the valve.
The experiments in vitro yielded two forms of results: technical -related to the inflation procedure, and pathologic from examination of the ballooninflated conduits. Rupture of the balloons in the conduits was extremely difficult. The balloons distorted, extended proximally and distally along the shaft, and accepted a large increase over the usual volume before rupture, which occurred at 8 atmospheres in the 12 mm conduit and at over 11 atmospheres in the 14 and 16 mm conduits.
The conduits and valves were examined grossly and microscopically by one of us (F. J. S.) with no knowledge of which had standard inflation and which had balloon rupture. All conduits and valves dilated in vitro were intact without cuspal tears or commissural dehiscence. One of the six had several longitudinal tears in the porcine atrial muscle shelf that was incorporated into the valve during manufacture. This did not appear to compromise either patency or competence of this valve.
Discussion
Insertion of valve-containing conduits is needed in certain types of congenital heart surgery: repair of trun- The mechanism by which BD opens the stenotic valve is unclear. Whether commissural fusion of the leaflets was severed and/or immobile basilar hinge points were loosened was not determined in our study. In our limited surgical experience with stenotic bioprosthetic valves under direct vision, deterioration of THERAPY AND PREVENTION-VALVULAR HEART DISEASE the leaflets did not appear to be homogeneous, i.e., one leaflet was relatively intact while there was fusion of the other two leaflets. Since valve function seemed somewhat preserved after BD, it is possible that the surgical observation may be common and that BD separates the fused commissure.
The one porcine valve available for direct inspection after BD showed leaflets in the mid position with a proximal pannus that appeared to be more obstructive than the valve itself. It seems probable that this proximal narrowing developed after the BD since there was no evidence of this obstruction either by pressure measurement or angiography. If the pannus formed as a reaction to the BD, then the technique may be of limited usefulness. We suspect that this is not the case because in the other three patients there has been no evidence of return to high right ventricular pressure during follow-up, which has admittedly been short (9 to 12 months).
The unmasking of more distal obstruction by BD of the bioprosthetic valve is clinically important. Before BD, with severe valvular obstruction, the pulmonary artery pressure was very low, making the finding of a large distal pressure gradient quite unlikely. Furthermore, since the obstructive valve prevents delivery of a large, rapid bolus of contrast into the pulmonary arteries during angiography, visualization of stenosis at the distal anastomoses may be suboptimal. Echocardiography has been of limited assistance in these patients because imaging of the distal conduit is often very difficult and good angles with which to measure gradients by Doppler flow analysis have been unattainable. However, after BD of the valve, pulmonary artery pressure rises (figure 2), making distal gradients more determinable, and angiography can be used to better visualize the conduit-pulmonary artery connections. It is imperative to seek out these stenoses and dilate them concurrent with the valve dilatation since the residual distal obstructions may cause persistence of the right ventricular hypertension, which was the initial indication for intervention.
Despite the apparent safety of oversized balloons, we believe that balloon size should be similar to that of the valve anulus. Larger balloons will tolerate lower inflation pressures and therefore lesser hoop stress. Oversize balloons are unlikely to provide any advantage over a balloon similar in size to the valve. Second, our data shows that an adequate reduction in gradient can be achieved with valve-sized balloons. Thus, balloons similar in size to the valve anulus should be chosen. However, there is some leeway, i.e., when the valve is 14 mm, a 15 mm balloon would seem superior to a 12 mm balloon, and a 20 mm balloon would probably be appropriate for a 16 mm conduit.
When stenosis of a bioprosthetic valve is found, it should be dilated first because it is quite safe and after BD, distal stenoses may be more apparent. After BD of the valve, angulated angiography of the pulmonary arteries should be performed. The lateral plane in approximately 20 degrees of cranial obliquity seems to separate the ostia of the two branches well (figure 2).
Indications for BD of stenotic bioprosthetic pulmonary valves cannot be derived from our study. We continue to use the level of systemic (or near systemic) right ventricular pressure as an indication for intervention, but it is possible that the indications should be liberalized because BD is extremely safe, does not require thoracotomy, and may even be repeated. If echocardiography does not provide data of a reassuring nature with respect to the right ventricular pressure, we recommend early diagnostic cardiac catheterization, with the physician prepared to perform BD if stenosis of the valve is encountered.
It may be appropriate to perform BD of a stenotic bioprosthetic valve even when replacement will be necessary in the immediate future. If the patient has suprasystemic right ventricular pressure, even a mild reduction in right ventricular pressure overload may decrease the risk of anesthetizing the patient for the surgery.
The finding of the obstructive pannus in the conduit in patient 1 is of concern. It is unlikely that this was present at the time of BD and therefore it developed in the 5 months between BD and conduit replacement. If 
